Sidra Medicine Announces Strategic Partners, Sponsors, and Start-Up Innovators for PMFG Summit 2025

Innovation remains the DNA of the Precision Medicine and the Future of Genomics Summit

18 November 2025 — Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, unveils the official line-up of strategic partners, sponsors, and innovators participating in the upcoming Precision Medicine and the Future of Genomics (PMFG) Summit from 2 to 4 December 2025 at Qatar National Convention Centre (QNCC).

Building on the Summit’s legacy as the region’s leading platform for advancing personalized healthcare, PMFG 2025 will once again bring together global experts, research pioneers, industry leaders, and emerging innovators to explore breakthroughs shaping the future of precision medicine.

Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: “PMFG 2025 is a celebration of eleven years of scientific discovery and innovation in precision medicine. The summit highlights cutting-edge research and advances in genomics, healthcare technologies and clinical precision medicine implementation, bringing global expertise to the region.”

Partners and Sponsors Driving Global Collaboration

This year’s Summit will be held in collaboration with key institutional and industry partners including the Qatar Precision Health Institute (QPHI); the Ministry of Communications and Information Technology (MCIT); Children’s Hospital of Philadelphia (CHOP) and Mass General Brigham Hospital (MGB), serving as Knowledge Partners. Invest Qatar and Qatar Free Zone join as strategic partners and titanium sponsors, while MedTech Corporation lead the sponsorship as Diamond Sponsors, alongside with CISCO, Quantinuum, GBM and Compass Qatar as Platinum sponsors.

Dr. Ammira Al-Shabeeb Akil, Scientific Outreach and Business Development Chair, PMFG Summit 2025, and Director of Mendelian and Metabolic Disorders Research Program, said: “Our focus has been on building the infrastructure that makes PMFG Summit 2025 a hub for innovation. From securing sponsors and partners to launching the Startups Hub, our goal is to give entrepreneurs and researchers the platform to showcase their work and translate ideas into real-world impact. Their participation underscores a shared commitment to accelerating translational research, clinical innovation, and capacity-building that contribute to regional and global health outcomes.”

Dr. Emmanouil Dermitzakis, President of Qatar Precision Health Institute (QPHI) added: “Our partnership with Sidra Medicine for PMFG 2025 reflects a shared commitment to advancing precision health through innovation, collaboration, and real-world implementation. At QPHI, we believe that transforming healthcare begins with the integration of data, genomics, and technology to create impact at both the individual and population levels. PMFG serves as an essential platform where science meets strategy, driving the future of personalized medicine not only for Qatar but for the region and the world.”

The Startup Hub: Innovation at the Core of PMFG

Reaffirming that innovation is the DNA of PMFG, Sidra Medicine is proud to launch the PMFG Startup Hub — an initiative led by its Research Branch in collaboration with the Ministry of Communications and Information Technology (MCIT) and Qatar Science and Technology Park (QSTP).

The Hub provides a dynamic platform for visionary entrepreneurs from Qatar and beyond to showcase innovations transforming healthcare, biotech, and digital health. Through live pitches and exhibits, it connects startups with investors, mentors, and industry leaders — reflecting Sidra Medicine’s commitment to empowering the next generation of health technology pioneers.

Ms. Eman Al Kuwari, Director of the Digital Innovation Department at the Ministry of Communications and Information Technology, said: “Our participation in PMFG 2025 reflects our commitment to fostering a strong digital innovation ecosystem, where emerging technologies including AI, big data, and cloud infrastructure drive advancements in precision medicine and genomics. Through our enablement and entrepreneurship programs, we support a growing pipeline of high-potential digital health startups by empowering these ventures, accelerating commercialization, and creating new opportunities for market expansion. Platforms like PMFG strengthen national capabilities and enable more data-driven research and human-centered healthcare solutions, advancing the goals of the Digital Agenda 2030.”

Registration

PMFG Summit 2025 continues to attract participation from healthcare professionals, researchers, academic institutions, policymakers, and patient advocates eager to contribute to the evolving dialogue shaping the next decade of personalized medicine.

The three-day program will feature keynote lectures, panel discussions, and masterclasses focused on AI in Genomics, Clinical Trials, and Precision Medicine Implementation. The Summit aims to bridge the gap between research and clinical practice, fostering an environment where ideas translate into impactful, real-world applications.

Register now at https://www.sidra.org/pmfg/ and be part of the transformation.